Study of Apatinib as the Maintenance Therapy in Advanced Lung Adenocarcinoma
Status:
Unknown status
Trial end date:
2019-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to confirm the safety and efficacy of Apatinib plus Pemetrexed
as the Maintenance Therapy in Advanced Lung Adenocarcinoma.